Author： Badia X.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.22, Iss.9, 2004-01, pp. : 591-603
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Indirect costs account for majority of migraine cost burden in Spain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. :
Access to resources
Recommend
The Economic Burden of Migraine to Society
By Ferrari M.D.
PharmacoEconomics, Vol. 13, Iss. 6, 1998-06 ,pp. :
Inappropriate treatment for COPD leads to high direct costs in Spain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :
ED visit costs for migraine hefty in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 440, 2003-01 ,pp. :
Migraine drug-specific coverage maximum lowers costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. :